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Before the widespread introduction of antiretroviral 
therapy (ART), most perinatally infected children did 
not survive beyond the first 2 years of life.1 With treat-
ment, HIV-positive children are living longer. In the de-
veloped world, where HAART has been widely available 
since 1996, survival of perinatally infected children 
into adolescence is now the norm.  Of a French cohort 
of perinatally infected children born before 1993, 58% 
were still alive and receiving HIV care 13 years later.2 
In the UK the proportion of HIV-infected children in 
care aged 10 - 19 years increased from 11% to 44% 
between 1996 and 2005.3 As HAART becomes increas-
ingly available in South Africa, we can expect similar 
trends. 
In addition to a growing population of vertically in-
fected adolescents in South Africa, youth are among 
those at greatest risk of HIV acquisition.4 Uptake of 
voluntary counselling and testing is low in adolescents, 
with only 20% of youth ever having had an HIV test5 
and even fewer engaging with the health care system 
for CD4 monitoring and health maintenance. At youth 
centres in the Cape Metropole, catering to 15 - 25-
year-olds only, testing uptake is 85% and two-thirds 
go on to receive CD4 counts (Karen Jennings, personal 
communication). Although most horizontally infected 
adolescents are not in immediate need of treatment, 
they could benefit from care and certainly from knowl-
edge of their HIV status. 
Mathematical models can be used to project the growth 
in the numbers of adolescents needing antiretroviral 
treatment in South Africa. The ASSA2003 AIDS and De-
mographic model,6,7 updated to reflect recent data on 
prevention of mother-to-child transmission8 and pae-
diatric survival on antiretroviral treatment,9 estimates 
that by the middle of 2008, approximately 6 000 youth 
aged 10 - 19 were receiving highly active antiretro-
viral therapy (HAART) and a further 6 000 met entry 
criteria for HAART. If it is assumed that South Africa 
meets the National Strategic Plan target of providing 
antiretroviral treatment to 80% of all individuals pro-
gressing to AIDS,10 the number of adolescents receiving 
antiretroviral treatment can be expected to increase to 
153 000 by 2020. While youth aged 10 - 19 accounted 
for only 1% of the total number of patients receiving 
HAART in 2008, this proportion is expected to grow 
to approximately 5% by 2020, mainly as a result of 
vertically infected children surviving into adolescence. 
Treatment and care for HIV-positive adolescents will 
therefore become increasingly important over the next 
decade. This contrasts with other chronic childhood 
illnesses such as rheumatic heart disease, where the 
prevalence is declining. For example an estimated 46 
cases of acute rheumatic fever were reported in 2002 
in adolescents aged 10 - 19 years, only some of whom 
went on to develop rheumatic heart disease.11
Adolescent health care is distinct from both paediatric 
and adult heath care because of the physiological and 
psychosocial transitions that occur during this period. 
HIV interferes with these normal developmental proc-
esses by delaying physical and intellectual development. 
In addition, HIV-positive adolescents confront many 
extra challenges, including concerns about medication 
regimens, doctors’ appointments, life expectancy, so-
cial upheaval, disclosure, stigmatisation, transmission 
of virus to others and the fear of being ‘abnormal’. The 
combination of HIV-related issues that are common 
to any age group and the extensive and rapid changes 
of adolescence create an exceptional and formidable 
challenge for both young people themselves and the 
adults who care for them.
Providing quality care and treatment for HIV-positive 
adolescents requires distinct needs to be addressed:
n  Young people living with HIV require knowledge 
and understanding of their HIV status. Disclosure of 
status at this age is paramount, although often not 
easy to accomplish. Once aware of their serostatus, 
adolescents require frank ongoing communication 
and education to ensure understanding of the im-
plications and acceptance of living with their ill-
ness. While often deferred in childhood, disclosure is 
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crucial during adolescence as individuals approach 
cognitive maturity.12 Significant adults may need to 
be guided and supported in this process. 
n  HIV places multiple stressors on the life of the ado-
lescent, including side-effects from medication, 
chronic illness, real or perceived stigma, and fre-
quently the death of family members. Young peo-
ple living with HIV may struggle to achieve mental 
health. North American research has described high 
rates of mental disorders among HIV-infected ado-
lescents, although it remains unclear whether these 
problems are associated with the virus itself or 
other environmental factors.13 Whatever the cause, 
evidence suggests that young people living with HIV 
need appropriate psychological services for adjust-
ment and survival of the youth into adulthood. This 
is particularly important given that mental health 
status affects HAART adherence and engagement in 
risky sexual behaviour.14,15 
n  Adolescents need social, emotional, spiritual, and 
often material support.16 Often HIV-infected ado-
lescents are alienated from their peers.17 Support 
groups can provide this support where peers do 
not. However, such groups cannot replace support 
for daily living, where additional assistance is often 
required. 
n  Because adherence to treatment and treatment pro-
grammes is integral for sustaining positive health 
outcomes, HIV-positive young people need support 
in managing their treatment. During childhood, care-
givers are often heavily involved in their children’s 
daily routines, and provide instrumental help in tak-
ing tablets. However, as children grow up, expecta-
tions for them to take increasing responsibility for 
their medication and clinic appointments emerge. 
Among adolescents adherence is a major problem, 
and studies suggest that compliance during this pe-
riod is lower than in other stages of life.18-20 This is 
probably due to disease denial,21 peer pressure and 
social norms, rebelliousness and risk-taking behav-
iour, among other reasons. In a local large, private 
sector, sub-Saharan African programme, where 
adolescents were treated similarly to adults, the 
adolescent patients were 1.5 times less likely to be 
virologically suppressed at one year, due to poorer 
adherence.20 Adolescents therefore need targeted 
interventions that enhance adherence and promote 
responsible treatment management.  
n  Finally, young people living with HIV need to learn 
how to make healthy decisions about reproductive 
and sexual health. Like their HIV-negative peers, 
HIV-positive adolescents will be maturing sexually 
and will have questions about their ability to date 
and engage in sexual activity.23,24 With sexual be-
haviour comes the potential for unwanted pregnan-
cy, acquisition of other sexually transmitted infec-
tions, re-infection with more pathogenic virus, and 
transmission of the virus to others. The potential 
costs of unsafe sex are therefore exceptionally high 
for infected young people and their partners. Young 
people need age-specific sexual and reproductive 
health services, and information and counselling 
to minimise risky sexual behaviour and encourage 
positive sexual identities.24 
We are currently in a critical moment of transition, dur-
ing which the first generation of perinatally infected 
South African children are navigating their way through 
adolescence. As numbers increase, we need to plan 
for their distinct needs. Multidisciplinary adolescent- 
specific programmes, addressing both the biomedical 
and the psychosocial aspects of living with HIV, would 
help prevent young people from falling through the 
cracks of paediatric or adult-orientated health care 
services. A few such interventions, such as the Nation-
al Adolescent Friendly Clinic Initiative, have already 
been implemented in a number of clinics and hospitals 
around the country25 and should be monitored, evalu-
ated, and expanded. 
Adolescent-targeted care is a glaring gap in our health 
care system, where we have neither specialists nor 
wards to cater for teenagers with chronic illness. En-
docrinologists, cardiologists, oncologists, and other 
specialities that care for adolescents in South Africa 
have been struggling with this challenge for years.26,27 
The HIV epidemic, with its unprecedented numbers and 
characteristic disease burden in youth, may provide the 
impetus for the South African medical system to ad-
dress the specific needs of our adolescent population. 
Failing to do so may jeopardise the longevity of more 
than 150 000 adolescents requiring HAART in the next 
decade.
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